A micro-bioimpedance meter for monitoring insulin bioavailability in personalized diabetes therapy

Abstract An on-chip transducer, for monitoring noninvasively the insulin bio-availability in real time after administration in clinical diabetology, is proposed. The bioavailability is assessed as insulin decrease in situ after administration by means of local impedance measurement. Inter-and-intra...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Pasquale Arpaia, Umberto Cesaro, Mirco Frosolone, Nicola Moccaldi, Maurizio Taglialatela
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2020
Materias:
R
Q
Acceso en línea:https://doaj.org/article/e7fc7851ec154676b636f8f884dbe56d
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:e7fc7851ec154676b636f8f884dbe56d
record_format dspace
spelling oai:doaj.org-article:e7fc7851ec154676b636f8f884dbe56d2021-12-02T18:50:57ZA micro-bioimpedance meter for monitoring insulin bioavailability in personalized diabetes therapy10.1038/s41598-020-70376-52045-2322https://doaj.org/article/e7fc7851ec154676b636f8f884dbe56d2020-08-01T00:00:00Zhttps://doi.org/10.1038/s41598-020-70376-5https://doaj.org/toc/2045-2322Abstract An on-chip transducer, for monitoring noninvasively the insulin bio-availability in real time after administration in clinical diabetology, is proposed. The bioavailability is assessed as insulin decrease in situ after administration by means of local impedance measurement. Inter-and-intra individual reproducibility is enhanced by a personalized model, specific for the subject, identified and validated during each insulin administration. Such a real-time noninvasive bioavailability measurement allows to increase the accuracy of insulin bolus administration, by attenuating drawbacks of glycemic swings significantly. In the first part of this paper, the concept, the architecture, and the operation of the transducer, as well as details about its prototype, are illustrated. Then, the metrological characterization and validation are reported in laboratory, in vitro on eggplants, ex vivo on pig abdominal non-perfused muscle, and in vivo on a human subject, using injection as a reference subcutaneous delivery of insulin. Results of significant intra-individual reproducibility in vitro and ex vivo point out noteworthy scenarios for assessing insulin bioavailability in clinical diabetology.Pasquale ArpaiaUmberto CesaroMirco FrosoloneNicola MoccaldiMaurizio TaglialatelaNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 10, Iss 1, Pp 1-11 (2020)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Pasquale Arpaia
Umberto Cesaro
Mirco Frosolone
Nicola Moccaldi
Maurizio Taglialatela
A micro-bioimpedance meter for monitoring insulin bioavailability in personalized diabetes therapy
description Abstract An on-chip transducer, for monitoring noninvasively the insulin bio-availability in real time after administration in clinical diabetology, is proposed. The bioavailability is assessed as insulin decrease in situ after administration by means of local impedance measurement. Inter-and-intra individual reproducibility is enhanced by a personalized model, specific for the subject, identified and validated during each insulin administration. Such a real-time noninvasive bioavailability measurement allows to increase the accuracy of insulin bolus administration, by attenuating drawbacks of glycemic swings significantly. In the first part of this paper, the concept, the architecture, and the operation of the transducer, as well as details about its prototype, are illustrated. Then, the metrological characterization and validation are reported in laboratory, in vitro on eggplants, ex vivo on pig abdominal non-perfused muscle, and in vivo on a human subject, using injection as a reference subcutaneous delivery of insulin. Results of significant intra-individual reproducibility in vitro and ex vivo point out noteworthy scenarios for assessing insulin bioavailability in clinical diabetology.
format article
author Pasquale Arpaia
Umberto Cesaro
Mirco Frosolone
Nicola Moccaldi
Maurizio Taglialatela
author_facet Pasquale Arpaia
Umberto Cesaro
Mirco Frosolone
Nicola Moccaldi
Maurizio Taglialatela
author_sort Pasquale Arpaia
title A micro-bioimpedance meter for monitoring insulin bioavailability in personalized diabetes therapy
title_short A micro-bioimpedance meter for monitoring insulin bioavailability in personalized diabetes therapy
title_full A micro-bioimpedance meter for monitoring insulin bioavailability in personalized diabetes therapy
title_fullStr A micro-bioimpedance meter for monitoring insulin bioavailability in personalized diabetes therapy
title_full_unstemmed A micro-bioimpedance meter for monitoring insulin bioavailability in personalized diabetes therapy
title_sort micro-bioimpedance meter for monitoring insulin bioavailability in personalized diabetes therapy
publisher Nature Portfolio
publishDate 2020
url https://doaj.org/article/e7fc7851ec154676b636f8f884dbe56d
work_keys_str_mv AT pasqualearpaia amicrobioimpedancemeterformonitoringinsulinbioavailabilityinpersonalizeddiabetestherapy
AT umbertocesaro amicrobioimpedancemeterformonitoringinsulinbioavailabilityinpersonalizeddiabetestherapy
AT mircofrosolone amicrobioimpedancemeterformonitoringinsulinbioavailabilityinpersonalizeddiabetestherapy
AT nicolamoccaldi amicrobioimpedancemeterformonitoringinsulinbioavailabilityinpersonalizeddiabetestherapy
AT mauriziotaglialatela amicrobioimpedancemeterformonitoringinsulinbioavailabilityinpersonalizeddiabetestherapy
AT pasqualearpaia microbioimpedancemeterformonitoringinsulinbioavailabilityinpersonalizeddiabetestherapy
AT umbertocesaro microbioimpedancemeterformonitoringinsulinbioavailabilityinpersonalizeddiabetestherapy
AT mircofrosolone microbioimpedancemeterformonitoringinsulinbioavailabilityinpersonalizeddiabetestherapy
AT nicolamoccaldi microbioimpedancemeterformonitoringinsulinbioavailabilityinpersonalizeddiabetestherapy
AT mauriziotaglialatela microbioimpedancemeterformonitoringinsulinbioavailabilityinpersonalizeddiabetestherapy
_version_ 1718377478476529664